Indications: Iracet, containing levetiracetam, is indicated as:  

• Monotherapy:In the treatment of partial-onset seizures with or without secondary generalization in adults and adolescentsfrom 16 years of age with newly diagnosed epilepsy.  
• Adjunctive therapy:  
  • In the treatment of partial-onset seizures with or without secondary generalizationin adults, adolescents, children, and infants from 1 month of age with epilepsy.  
  • In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.  
  • In the treatment of primary generalizedtonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic GeneralizedEpilepsy.

Dosage and Administration: Iracet can be administered orally as tablets or solution. The dosage depends on the indication, age, weight, and renal function of the patient.

• Adults and adolescents (≥16 years): The usual starting dose is 500 mg twice daily. The dose can be adjusted based on clinical response and tolerability, with a maximum recommended daily dose of 3000 mg.
• Children: Dosage is weight-based for younger children and may vary by age. Oral solution is often preferred for infants and young children.
• Renal Impairment: Dosage adjustment is required in patients with impaired renal function, based on creatinine clearance.

Side Effects:

• Very Common: Somnolence, asthenia (weakness), headache.
• Common: Dizziness, fatigue, aggression, irritability, anxiety, depression, nervousness, ataxia (lack of coordination), tremor, amnesia, convulsion, nausea, vomiting, diarrhea, abdominal pain, diplopia (double vision), blurred vision, infection, nasopharyngitis, cough, rash.
• Rare: Suicidal thoughts or behavior, behavioral changes, psychotic disorders, pancytopenia, leukopenia, neutropenia.

Precautions:

• Use with caution in patients with renal impairment; dosage adjustment may be necessary.
• Levetiracetam may cause drowsiness and dizziness, affecting the ability to drive or operate machinery.
• Monitor patients for signs of depression and/or suicidal ideation and behavior.
• Inform the doctor about any existing medical conditions and all other medications being taken.
• Use in pregnancy and breastfeeding should be considered only if clearly needed and under medical supervision.

Storage: Store below 30°C, protected from moisture. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.